These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 39153721)

  • 1. An "Iron-phagy" nanoparticle inducing irreversible mitochondrial damages for antitumor therapy.
    Wang Z; Xiang S; Qiu Y; Yu F; Li S; Zhang S; Song G; Xu Y; Meng T; Yuan H; Hu F
    J Control Release; 2024 Oct; 374():400-414. PubMed ID: 39153721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anticancer agent di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes prosurvival autophagy by two mechanisms: persistent induction of autophagosome synthesis and impairment of lysosomal integrity.
    Gutierrez E; Richardson DR; Jansson PJ
    J Biol Chem; 2014 Nov; 289(48):33568-89. PubMed ID: 25301941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel di-2-pyridyl-derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment.
    Yuan J; Lovejoy DB; Richardson DR
    Blood; 2004 Sep; 104(5):1450-8. PubMed ID: 15150082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Anticancer Agent, Di-2-Pyridylketone 4,4-Dimethyl-3-Thiosemicarbazone (Dp44mT), Up-Regulates the AMPK-Dependent Energy Homeostasis Pathway in Cancer Cells.
    Krishan S; Richardson DR; Sahni S
    Biochim Biophys Acta; 2016 Dec; 1863(12):2916-2933. PubMed ID: 27639899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Mitochondrial Iron Metabolism Suppresses Tumor Growth and Metastasis by Inducing Mitochondrial Dysfunction and Mitophagy.
    Sandoval-Acuña C; Torrealba N; Tomkova V; Jadhav SB; Blazkova K; Merta L; Lettlova S; Adamcová MK; Rosel D; Brábek J; Neuzil J; Stursa J; Werner L; Truksa J
    Cancer Res; 2021 May; 81(9):2289-2303. PubMed ID: 33685989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translocation of iron from lysosomes to mitochondria during acetaminophen-induced hepatocellular injury: Protection by starch-desferal and minocycline.
    Hu J; Kholmukhamedov A; Lindsey CC; Beeson CC; Jaeschke H; Lemasters JJ
    Free Radic Biol Med; 2016 Aug; 97():418-426. PubMed ID: 27345134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of metal-chelating compound Dp44mT is mediated by formation of a redox-active copper complex that accumulates in lysosomes.
    Lovejoy DB; Jansson PJ; Brunk UT; Wong J; Ponka P; Richardson DR
    Cancer Res; 2011 Sep; 71(17):5871-80. PubMed ID: 21750178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor- and mitochondria-targeted nanoparticles eradicate drug resistant lung cancer through mitochondrial pathway of apoptosis.
    Wang H; Zhang F; Wen H; Shi W; Huang Q; Huang Y; Xie J; Li P; Chen J; Qin L; Zhou Y
    J Nanobiotechnology; 2020 Jan; 18(1):8. PubMed ID: 31918714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significantly enhanced tumor cellular and lysosomal hydroxychloroquine delivery by smart liposomes for optimal autophagy inhibition and improved antitumor efficiency with liposomal doxorubicin.
    Wang Y; Shi K; Zhang L; Hu G; Wan J; Tang J; Yin S; Duan J; Qin M; Wang N; Xie D; Gao X; Gao H; Zhang Z; He Q
    Autophagy; 2016 Jun; 12(6):949-62. PubMed ID: 27123811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial Targeted Doxorubicin-Triphenylphosphonium Delivered by Hyaluronic Acid Modified and pH Responsive Nanocarriers to Breast Tumor: in Vitro and in Vivo Studies.
    Liu HN; Guo NN; Wang TT; Guo WW; Lin MT; Huang-Fu MY; Vakili MR; Xu WH; Chen JJ; Wei QC; Han M; Lavasanifar A; Gao JQ
    Mol Pharm; 2018 Mar; 15(3):882-891. PubMed ID: 29357260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial targeting nanodrugs self-assembled from 9-O-octadecyl substituted berberine derivative for cancer treatment by inducing mitochondrial apoptosis pathways.
    Song J; Lin C; Yang X; Xie Y; Hu P; Li H; Zhu W; Hu H
    J Control Release; 2019 Jan; 294():27-42. PubMed ID: 30445003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of autophagy and apoptosis by Dp44mT-mediated activation of AMPK in pancreatic cancer cells.
    Krishan S; Sahni S; Leck LYW; Jansson PJ; Richardson DR
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165657. PubMed ID: 31904416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production.
    Hamacher-Brady A; Stein HA; Turschner S; Toegel I; Mora R; Jennewein N; Efferth T; Eils R; Brady NR
    J Biol Chem; 2011 Feb; 286(8):6587-601. PubMed ID: 21149439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysosomal membrane stability plays a major role in the cytotoxic activity of the anti-proliferative agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT).
    Gutierrez EM; Seebacher NA; Arzuman L; Kovacevic Z; Lane DJ; Richardson V; Merlot AM; Lok H; Kalinowski DS; Sahni S; Jansson PJ; Richardson DR
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1665-81. PubMed ID: 27102538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic Acid-Bilirubin Nanoparticles as a Tumor Microenvironment Reactive Oxygen Species-Responsive Nanomedicine for Targeted Cancer Therapy.
    Lee S; Lee SA; Shinn J; Lee Y
    Int J Nanomedicine; 2024; 19():4893-4906. PubMed ID: 38828202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic induces pancreatic dysfunction and ferroptosis via mitochondrial ROS-autophagy-lysosomal pathway.
    Wei S; Qiu T; Yao X; Wang N; Jiang L; Jia X; Tao Y; Wang Z; Pei P; Zhang J; Zhu Y; Yang G; Liu X; Liu S; Sun X
    J Hazard Mater; 2020 Feb; 384():121390. PubMed ID: 31735470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics.
    Whitnall M; Howard J; Ponka P; Richardson DR
    Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14901-6. PubMed ID: 17003122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smart nanoparticles with a detachable outer shell for maximized synergistic antitumor efficacy of therapeutics with varying physicochemical properties.
    Yin T; Liu J; Zhao Z; Dong L; Cai H; Yin L; Zhou J; Huo M
    J Control Release; 2016 Dec; 243():54-68. PubMed ID: 27702595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The iron chelator Dp44mT inhibits the proliferation of cancer cells but fails to protect from doxorubicin-induced cardiotoxicity in spontaneously hypertensive rats.
    Rao VA; Zhang J; Klein SR; Espandiari P; Knapton A; Dickey JS; Herman E; Shacter EB
    Cancer Chemother Pharmacol; 2011 Nov; 68(5):1125-34. PubMed ID: 21373894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overendocytosis of superparamagnetic iron oxide particles increases apoptosis and triggers autophagic cell death in human osteosarcoma cell under a spinning magnetic field.
    Du S; Li J; Du C; Huang Z; Chen G; Yan W
    Oncotarget; 2017 Feb; 8(6):9410-9424. PubMed ID: 28031531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.